JP Morgan Reiterates Neutral Rating on Quest Diagnostics Incorporated (DGX)
Rating Change JP Morgan analysts reiterated a Neutral rating on Quest Diagnostics Incorporated (NYSE:DGX) on July 28, 2026. Market Context Quest Diagnostics Incorporated operates…
Read more
